F
Foghorn Therapeutics Inc. (FHTX)
NGM – Real Time Price. Currency in USD
4.24
-0.09 (-2.08%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
4.24
-0.09 (-2.08%)
At close: May 12, 2026, 4:00 PM EDT
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing therapies for mutant; non-small cell lung; endometrial, cervical, ovarian, and bladder cancer; and diffuse large B-cell lymphoma, as well as various acute myeloid leukemia and myelodysplastic syndrome. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
| Name | Position |
|---|---|
| Dr. Alfonso Quintas Cardama M.D. | Chief Medical Officer |
| Dr. Anna Rivkin Ph.D. | Chief Business Officer |
| Dr. Gerald R. Crabtree M.d. | Founder & Member of Scientific Advisory Board |
| Dr. Steven F. Bellon Ph.D. | Chief Scientific Officer |
| Mr. Adrian H. B. Gottschalk | President, CEO & Director |
| Mr. Carlos Costa | Chief People Officer |
| Mr. Michael J. LaCascia J.D. | Chief Legal Officer |
| Mr. Ryan D. Maynard | Chief Financial Officer |
| Mr. Saurabh Sewak Ph.D. | Vice President of Corporate Development |
| Ms. Karin Hellsvik | Chief of Staff to the CEO, VP, Head of Corporate Affairs, Investor Relations & Operations |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | fhtx-20260507.htm |
| 2026-05-07 | 10-Q | fhtx-20260331.htm |
| 2026-04-30 | DEF 14A | d116077ddef14a.htm |
| 2026-04-21 | 8-K | fhtx-20260421.htm |
| 2026-03-26 | S-8 | s-82026evergreensharesjanu.htm |
| 2026-03-11 | 8-K | fhtx-20260311.htm |
| 2026-02-23 | 8-K | fhtx-20260223.htm |
| 2025-12-04 | 8-K | fhtx-20251203.htm |
| 2025-11-07 | 8-K | fhtx-20251107.htm |
| 2025-11-05 | 8-K | fhtx-20251105.htm |